300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Costa Rica
Colombia
China
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

Yukyung PSG Asset Management

VC Fund

Yukyung PSG Asset Management is a VC fund focused on Health Care and Biotechnology. Yukyung PSG Asset Management

Total investments:
13
Last investment:
Lead investor:
0%

Last updated:

Industries Yukyung PSG Asset Management invests in

Health CareBiotechnologyLivestockBeautyFarming

Stages Yukyung PSG Asset Management invests in

Series BSeries ASeries CVenture - Series UnknownSeed

Countries Yukyung PSG Asset Management invests in

South Korea

Round sizes

Series A $2.6M–$7.8MSeries B $17M–$27MSeries C $18M–$37M

Round size

Series A
$2.6M–$7.8M
Series B
$17M–$27M
Series C
$18M–$37M

Investment Focus

Industry

  • Health Care 3 (23%)
  • Biotechnology 3 (23%)
  • Livestock 2 (15%)
  • Beauty 1 (8%)
  • Farming 1 (8%)
See all 26 industries →

Stage

  • Series B 4 (31%)
  • Series A 3 (23%)
  • Series C 2 (15%)
  • Venture - Series Unknown 2 (15%)
  • Seed 1 (8%)
See all 6 stages →

Investments

CompanyDescriptionRoundLinks
BRLab offers a framework that makes it possible to implement sophisticated sleep analysis and enhancement techniques. The solutions are based on a unique sleep-enhancing technology that is scientifically validated and patented, as well as an AI-powered algorithm with the highest level of reliability. $5.4M / Venture - Series Unknown / Feb 21, 2023
Hyperlounge is a startup that has developed a monthly subscription management analysis SaaS by combining management consulting know-how with data collection, analysis and visualization technology. It is a specialized system for small and medium-sized business executives, which is completely different from existing data analysis tools or services.When using this service, user can easily check the core data and analysis necessary for business management every day on mobile without the burden of initial investment or recruitment. $7.8M / Series A / Nov 22, 2022
Curocell’s OVIS™ technology enhances immune cells to overcome immune suppression in tumor microenvironments. $30.1M / Venture - Series Unknown / Jan 04, 2022
Conbini store offers local food and specialty items. Series B / Dec 23, 2021
Lowe is a shared beauty salon platform service that provides a variety of beauty infrastructure such as beauty spaces, facilities and materials, and creates an optimal environment for designers to focus on the essence. $2.9M / Series A / Nov 22, 2021
Korea Credit Data provides essential services for merchants in Korea including business management, customer analysis, POS and payment services as well as marketplace platform. KCD and its six subsidiaries currently serve more than two million businesses in Korea. KCD aims to resolve issues a business owner faces from the beginning to end of hisbusiness life. To this end, KCD expands its business areas to include payment(Korea Payment Networks), POS(IMU), and credit bureau(Korea Credit Service) which obtained a CB license for the first time in 17 years.KCD made strong strategic partnerships with industry leading companies and built a high entry barrier; the company raised $220M+ from Temasek(Pavilion Capital), Morgan Stanley(Tactical Value), Kakao(No.1 mobile platform in Korea), KB Kookmin Bank(No.1 retail bank in Korea), Hanwha Life Insurance, Shinhan Card(No.1 credit card company in Korea), Dunamu(No.1 cryptocurrency exchange in Korea 'Upbit'), GS Holdings(No.1 CVS in Korea 'GS25'), Fiserv(the largest non-bank merchant acquirer) and more. $28.1M / Series D / Nov 17, 2021
Animal Industry Data Korea is a livestock healthcare solution provider company. $16.9M / Series B / Nov 03, 2021
Tomocube’s is dedicated to delivering products that can enhance biological and medical research via novel optical solutions that can assist Tomocube in understanding, diagnosing, and treating human diseases.Current optical microscopes only provide users with a 2D view of their sample. To get a 3D view, users must use expensive and invasiveelectron or confocal microscopes, which require extensive pre-preparation of samples and are not amenable to dynamic samples such as live cells. Their platform enables researchers to measure nanoscale, real-time, dynamic images of individual living cells without the need for sample preparation. $18M / Series C / Sep 23, 2021
Newracle Genetics is a bio venture company that develops gene therapy products for neurological diseases. $26.9M / Series B / Jun 03, 2021
IR KUDOS is a consulting agency that offers IPR, IPO, and strategic consulting services. $2.6M / Series A / May 17, 2021
See all 13 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Retail
Film
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Tunisia
Sweden
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Poland
Oman
Puerto Rico
Guernsey
Cameroon
Costa Rica
Colombia
China
Armenia
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Morocco
Seychelles
Moldova
Botswana
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Cyprus
Spain
Qatar
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Yukyung PSG Asset Management invest in?

Yukyung PSG Asset Management invests primarily in Health Care, Biotechnology and Livestock startups, most often at Series B and Series A stage. Most of the 13 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Yukyung PSG Asset Management invest in?

Yukyung PSG Asset Management typically joins rounds of $2.6M–$7.8M at Series A, $17M–$27M at Series B and $18M–$37M at Series C. These are whole funding-round sizes, not Yukyung PSG Asset Management's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Yukyung PSG Asset Management took part in.

When did Yukyung PSG Asset Management last invest?

The most recent investment recorded for Yukyung PSG Asset Management closed in Feb 2023. Shizune tracks 13 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Yukyung PSG Asset Management Find emails